Global Hepatology Market Size, Share, and COVID-19 Impact Analysis, By Treatment Type (Antiviral Drugs, Vaccines, Immunosuppressants, Targeted Therapy, Chemotherapy, Corticosteroids, Immunoglobulins), By Disease Type (Hepatitis, Liver Cancer, Genetic Disorders, Autoimmune Diseases, Non- Alcoholic Fatty Liver Diseases, Others), and By Region (North America, Europe, Asia-Pacific, Latin America, Middle East, and Africa), Analysis and Forecast 2023 - 2033.

Industry: Healthcare

RELEASE DATE Feb 2026
REPORT ID SI3950
PAGES 200
REPORT FORMAT PathSoft

  1. Introduction
    1. Objectives of the Study
    2. Market Definition
    3. Research Scope
  2. Research Methodology and Assumptions
  3. Executive Summary
  4. Premium Insights
    1. Porter’s Five Forces Analysis
    2. Value Chain Analysis
    3. Top Investment Pockets
      1. Market Attractiveness Analysis By Treatment Type
      2. Market Attractiveness Analysis By Disease Type
      3. Market Attractiveness Analysis By Region
    4. Industry Trends
  5. Market Dynamics
    1. Market Evaluation
    2. Drivers
      1. Rising global prevalence of liver diseases, especially NAFLD and viral hepatitis, plus growing public awareness.
    3. Restraints
      1.  High treatment and diagnostic costs restrict adoption, especially in low-income regions
    4. Opportunities
      1.  Novel therapies and diagnostics innovation expands treatment options and market potential
    5. Challenges

5.5.1.   Stringent regulations and limited access delay new treatments and uptake.

  1. Global Hepatology Market Analysis and Projection, By Treatment Type
    1. Segment Overview
    2. Antiviral Drugs
    3. Vaccines
    4. Immunosuppressants
    5. Targeted Therapy
    6. Others
  2. Global Hepatology Market Analysis and Projection, By Disease Type
    1. Segment Overview
    2. Hepatitis
    3. Liver Cancer
    4. Genetic Disorders
    5. Autoimmune Diseases
    6. Others
  3. Global Hepatology Market Analysis and Projection, By Regional Analysis
    1. Segment Overview
    2. North America
      1. U.S.
      2. Canada
      3. Mexico
    3. Europe
      1. Germany
      2. France
      3. U.K.
      4. Italy
      5. Spain
    4. Asia-Pacific
      1. Japan
      2. China
      3. India
    5. South America
      1. Brazil
    6. Middle East and Africa
      1. UAE
      2. South Africa
  4. Global Hepatology Market-Competitive Landscape
    1. Overview
    2. Market Share of Key Players in the Hepatology Market
      1. Global Company Market Share
      2. North America Company Market Share
      3. Europe Company Market Share
      4. APAC Company Market Share
    3. Competitive Situations and Trends
      1. Coverage Launches and Developments
      2. Partnerships, Collaborations, and Agreements
      3. Mergers & Acquisitions
      4. Expansions
  5. Company Profiles
    1. Astellas Pharma Inc
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    2.   AbbVie Inc 
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    3.  Zydus Lifesciences 
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    4.   Bristol-Myers Squibb Company 
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    5.   Takeda Pharmaceuticals Inc 
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    6.  Arrowhead Pharmaceuticals Inc
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    7.   Emergent BioSolutions Inc
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    8. F. Hoffmann- La Roche AG
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    9.  Eli Lilly and Company
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    10.  Viatris Inc. 
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    11.  Gilead Sciences, Inc.
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    12.   Merck & Co. Inc
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    13.  Others 
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis

List of Table

  1. Global Hepatology Market, By Treatment Type, 2024-2035(USD Billion)
  2. Global Antiviral Drugs, Hepatology Market, By Region, 2024-2035(USD Billion)
  3. Global Vaccines, Hepatology Market, By Region, 2024-2035(USD Billion)
  4. Global Immunosuppressants, Hepatology Market, By Region, 2024-2035(USD Billion)
  5. Global Targeted Therapy, Hepatology Market, By Region, 2024-2035(USD Billion)
  6. Global Others, Hepatology Market, By Region, 2024-2035(USD Billion)
  7. Global Hepatology Market, By Disease Type, 2024-2035(USD Billion)
  8. Global Hepatitis, Hepatology Market, By Region, 2024-2035(USD Billion)
  9. Global Liver Cancer, Hepatology Market, By Region, 2024-2035(USD Billion)
  10. Global Genetic Disorders, Hepatology Market, By Region, 2024-2035(USD Billion)
  11. Global Autoimmune Diseases, Hepatology Market, By Region, 2024-2035(USD Billion)
  12. Global Others, Hepatology Market, By Region, 2024-2035(USD Billion)
  13. North America Hepatology Market, By Treatment Type, 2024-2035(USD Billion)
  14. North America Hepatology Market, By Disease Type, 2024-2035(USD Billion)
  15. U.S.  Hepatology Market, By Treatment Type, 2024-2035(USD Billion)
  16. U.S.  Hepatology Market, By Disease Type, 2024-2035(USD Billion)
  17. Canada Hepatology Market, By Treatment Type, 2024-2035(USD Billion)
  18. Canada Hepatology Market, By Disease Type, 2024-2035(USD Billion)
  19. Mexico Hepatology Market, By Treatment Type, 2024-2035(USD Billion)
  20. Mexico Hepatology Market, By Disease Type, 2024-2035(USD Billion)
  21. Europe Hepatology Market, By Treatment Type, 2024-2035(USD Billion)
  22. Europe Hepatology Market, By Disease Type, 2024-2035(USD Billion)
  23. Germany Hepatology Market, By Treatment Type, 2024-2035(USD Billion)
  24. Germany Hepatology Market, By Disease Type, 2024-2035(USD Billion)
  25. France Hepatology Market, By Treatment Type, 2024-2035(USD Billion)
  26. France Hepatology Market, By Disease Type, 2024-2035(USD Billion)
  27. U.K.  Hepatology Market, By Treatment Type, 2024-2035(USD Billion)
  28. U.K.  Hepatology Market, By Disease Type, 2024-2035(USD Billion)
  29. Italy Hepatology Market, By Treatment Type, 2024-2035(USD Billion)
  30. Italy Hepatology Market, By Disease Type, 2024-2035(USD Billion)
  31. Spain Hepatology Market, By Treatment Type, 2024-2035(USD Billion)
  32. Spain Hepatology Market, By Disease Type, 2024-2035(USD Billion)
  33. Asia Pacific Hepatology Market, By Treatment Type, 2024-2035(USD Billion)
  34. Asia Pacific Hepatology Market, By Disease Type, 2024-2035(USD Billion)
  35. Japan Hepatology Market, By Treatment Type, 2024-2035(USD Billion)
  36. Japan Hepatology Market, By Disease Type, 2024-2035(USD Billion)
  37. China Hepatology Market, By Treatment Type, 2024-2035(USD Billion)
  38. China Hepatology Market, By Disease Type, 2024-2035(USD Billion)
  39. India Hepatology Market, By Treatment Type, 2024-2035(USD Billion)
  40. India Hepatology Market, By Disease Type, 2024-2035(USD Billion)
  41. South America Hepatology Market, By Treatment Type, 2024-2035(USD Billion)
  42. South America Hepatology Market, By Disease Type, 2024-2035(USD Billion)
  43. Brazil Hepatology Market, By Treatment Type, 2024-2035(USD Billion)
  44. Brazil Hepatology Market, By Disease Type, 2024-2035(USD Billion)
  45. The Middle East and Africa Hepatology Market, By Treatment Type, 2024-2035(USD   Billion)
  46. The Middle East and Africa Hepatology Market, By Disease Type, 2024-2035(USD   Billion)
  47. UAE Hepatology Market, By Treatment Type, 2024-2035(USD Billion)
  48. UAE Hepatology Market, By Disease Type, 2024-2035(USD Billion)
  49. South Africa Hepatology Market, By Treatment Type, 2024-2035(USD Billion)
  50. South Africa Hepatology Market, By Disease Type, 2024-2035(USD Billion)

List of Figures 

  1. Global Hepatology Market Segmentation
  2. Hepatology Market: Research Methodology
  3. Market Size Estimation Methodology: Bottom-Up Approach
  4. Market Size Estimation Methodology: Top-down Approach
  5. Data Triangulation
  6. Porter’s Five Forces Analysis
  7. Value Chain Analysis
  8. Top investment pocket in the Hepatology Market
  9. Top Winning Strategies, 2024-2035
  10. Top Winning Strategies, By Development, 2024-2035(%)
  11. Top Winning Strategies, By Company, 2024-2035
  12. Moderate Bargaining power of Buyers
  13. Moderate Bargaining power of Suppliers
  14. Moderate Bargaining power of New Entrants
  15. Low threat of Substitution
  16. High Competitive Rivalry
  17. Top Player Positioning, 2024
  18. Market Share Analysis, 2024
  19. Restraint and Drivers:  Hepatology Market
  20. Hepatology Market Segmentation, By Treatment Type
  21. Hepatology Market For Antiviral Drugs, By Region, 2024-2035 ($ Billion)
  22.  Hepatology Market For Vaccines, By Region, 2024-2035 ($ Billion)
  23. Hepatology Market For Immunosuppressants, By Region, 2024-2035 ($ Billion)
  24. Hepatology Market For Targeted Therapy, By Region, 2024-2035 ($ Billion)
  25. Hepatology Market For Others, By Region, 2024-2035 ($ Billion)
  26.  Hepatology Market Segmentation, By Disease Type
  27.  Hepatology Market For Hepatitis, By Region, 2024-2035 ($ Billion)
  28.  Hepatology Market For Liver Cancer, By Region, 2024-2035 ($ Billion)
  29. Hepatology Market For Genetic Disorders, By Region, 2024-2035 ($ Billion)
  30. Hepatology Market For Autoimmune Diseases, By Region, 2024-2035 ($ Billion)
  31. Hepatology Market For Others, By Region, 2024-2035 ($ Billion)
  32. AbbVie Inc: Net Sales, 2024-2035 ($ Billion)
  33. AbbVie Inc: Revenue Share, By Segment, 2024 (%)
  34. AbbVie Inc: Revenue Share, By Region, 2024 (%)
  35. Zydus Lifesciences: Net Sales, 2024-2035 ($ Billion)
  36. Zydus Lifesciences: Revenue Share, By Segment, 2024 (%)
  37. Zydus Lifesciences: Revenue Share, By Region, 2024 (%)
  38. Bristol-Myers Squibb Company: Net Sales, 2024-2035 ($ Billion)
  39. Bristol-Myers Squibb Company: Revenue Share, By Segment, 2024 (%)
  40. Bristol-Myers Squibb Company: Revenue Share, By Region, 2024 (%)
  41. Takeda Pharmaceuticals Inc: Net Sales, 2024-2035 ($ Billion)
  42. Takeda Pharmaceuticals Inc: Revenue Share, By Segment, 2024 (%)
  43. Takeda Pharmaceuticals Inc: Revenue Share, By Region, 2024 (%)
  44. Arrowhead Pharmaceuticals Inc: Net Sales, 2024-2035 ($ Billion)
  45. Arrowhead Pharmaceuticals Inc: Revenue Share, By Segment, 2024 (%)
  46. Arrowhead Pharmaceuticals Inc: Revenue Share, By Region, 2024 (%)
  47. Emergent BioSolutions Inc: Net Sales, 2024-2035 ($ Billion)
  48. Emergent BioSolutions Inc: Revenue Share, By Segment, 2024 (%)
  49. Emergent BioSolutions Inc: Revenue Share, By Region, 2024 (%)
  50. F. Hoffmann- La Roche AG: Net Sales, 2024-2035 ($ Billion)
  51. F. Hoffmann- La Roche AG: Revenue Share, By Segment, 2024 (%)
  52. F. Hoffmann- La Roche AG: Revenue Share, By Region, 2024 (%)
  53. Eli Lilly and Company.: Net Sales, 2024-2035 ($ Billion)
  54. Eli Lilly and Company.: Revenue Share, By Segment, 2024 (%)
  55. Eli Lilly and Company.: Revenue Share, By Region, 2024 (%)
  56. Viatris Inc.: Net Sales, 2024-2035 ($ Billion)
  57. Viatris Inc.: Revenue Share, By Segment, 2024 (%)
  58. Viatris Inc.: Revenue Share, By Region, 2024 (%)
  59. Gilead Sciences, Inc.: Net Sales, 2024-2035 ($ Billion)
  60. Gilead Sciences, Inc.: Revenue Share, By Segment, 2024 (%)
  61. Gilead Sciences, Inc.: Revenue Share, By Region, 2024 (%)
  62. Merck & Co. Inc: Net Sales, 2024-2035 ($ Billion)
  63. Merck & Co. Inc: Revenue Share, By Segment, 2024 (%)
  64. Merck & Co. Inc: Revenue Share, By Region, 2024 (%)
  65. Others: Net Sales, 2024-2035 ($ Billion)
  66. Others: Revenue Share, By Segment, 2024 (%)
  67. Others: Revenue Share, By Region, 2024 (%)

Need help to buy this report?

Inquiry Before Buy
We'll use cookies to improve and customize your experience if you continue to browse. Is it OK if we also use cookies to show you personalized ads?
Learn more and manage your cookies
Yes, Accept Cookies